Thermo Fisher Scientific Inc. Buyback
OLI recorded this information on 9/23/2021
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $3 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company's existing repurchase authorization, of which $500 million was remaining.
Thermo Fisher Scientific is engaged in serving science. Co.'s segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products for customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
Thermo Fisher Scientific SEC Filing Email Alerts Service
Open the TMO Page at The Online Investor »
Free TMO Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Strong Buy (3.84 out of 4)